Understanding Experiences of People Pausing HIV Treatment for Cure Research
Investigating Psychosocial Experiences of HIV Cure Trial Participants Undergoing Extended HIV Treatment Interruptions: Implications for Ethical Conduct
This project aims to understand the experiences and feelings of people living with HIV who temporarily stop their medication as part of research to find a cure.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11122193 on NIH RePORTER |
What this research studies
When scientists look for an HIV cure, they sometimes ask people living with HIV to pause their regular medication to see if the new treatment works. This project wants to learn about the experiences of these participants, especially during longer pauses in treatment. We will ask about their understanding of the process, their expectations, and any emotional effects. The goal is to make sure future HIV cure research is conducted in the most ethical and supportive way possible for everyone involved.
Who could benefit from this research
Good fit: Ideal candidates are people living with HIV who have participated in or are considering HIV cure research that involves pausing their antiretroviral treatment.
Not a fit: Patients not involved in HIV cure research or those who are not undergoing treatment interruptions would not directly benefit from this specific project.
Why it matters
Potential benefit: This work could help make future HIV cure research safer and more supportive for participants by addressing their concerns and improving the informed consent process.
How similar studies have performed: While the specific focus on psychosocial experiences during extended treatment interruptions in HIV cure research is relatively new, ethical considerations in clinical trials are a well-established field.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Sauceda, John Andrew — University of California, San Francisco
- Study coordinator: Sauceda, John Andrew
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.